Continuous granulation and drying system for r&d
In the pharmaceutical industry, developing a continuous granulation process at the research and development stage is crucial. This phase often involves limited quantities of active pharmaceutical ingredients (APIs) and requires controlled and efficient granulation and drying processes to ensure high granule quality.
Efficient continuous granulation and drying for r&d
The ConsiGma® GD 25/80 by GEA is a continuous twin-screw granulation and drying system designed for small-scale R&D operations. It offers standalone continuous twin-screw granulation and includes a small dryer segment, making it ideal for developing high-quality granules with quantities starting from a few hundred grams to a few kilograms. The system features a powder feeder, a liquid addition system, a twin-screw granulator, and a dryer segment. Optional configurations include solvent compatibility, a second liquid addition system, and a Lighthouse Probe® for loss on drying (LOD) measurement. The results obtained are directly transferrable to larger ConsiGma® GD or GC lines, facilitating a seamless transition from R&D to production.
Benefits
- Controlled granulation ensuring high granule quality
- Minimal use of APIs during R&D
- Fast research and development cycle
- Reduced time-to-market with no scale-up required
- Direct transferability to larger production lines